contact us
home

XIV
INTERNATIONAL SYMPOSIUM ON

DRUGS AFFECTING LIPID METABOLISM

SEPTEMBER 9-12, 2001
NEW YORK HILTON & TOWERS

 


PLENARY LECTURES


THE ARTERIAL WALL
  • INFLAMMATION AND ATHEROSCLEROSIS
    Peter Libby (Boston, MA USA)

  • PLASMA LIPIDS AND ENDOTHELIAL FUNCTION
    Carl J. Pepine (Gainesville, FL USA)*

  • PHOSPHOLIPASE A2 IN THE ARTERY WALL
    Eva Hurt-Camejo (Molndal, Sweden)

 

LIPIDS AND LIPOPROTEINS

  • HDL METABOLISM
    H. Bryan Brewer (Bethesda, MD USA)

  • HDL and ABC1
    Gerd Assmann (Munster, Germany)

  • ANTI-INFLAMMATORY PROPERTIES OF HDL
    Philip Barter (Adelaide, SA Australia)

  • HDL AS A THERAPEUTIC TARGET
    Daniel Rader (Philadelphia, PA USA)

  • PPARs alfa and gamma
    J.-C. Fruchart (Lille, France)

  • STATINS AND LIPIDS
    A.M. Gotto, Jr. (New York, NY USA)

  • STATINS AND THE ARTERIAL WALL
    R. Paoletti (Milan, Italy)

HIGH RISK POPULATIONS AND CVD: THE ELDERLY, HYPERTENSIVES AND WOMEN

  • LIPIDS MODIFICATION IN THE ELDERLY:
    DOES IT REDUCE STROKE AND OSTEOPOROSIS?
    James Shepherd (Glasgow, UK)

  • COMBINATION THERAPY FOR THE DYSLIPIDEMIC HYPERTENSIVE PATIENT
    Bertram Pitt (Ann Arbor, MI USA)

  • WOMEN: LIPIDS, HORMONES, AND CHD
    Elizabeth Barrett-Connor (La Jolla, CA USA)
HIGH RISK POPULATIONS AND CVD: DIABETES

  • THE IMPENDING EPIDEMIC OF DIABETES AND CHD
    Peter Wilson (Boston, MA USA)

  • PPARgamma LIGANDS, LIPIDS, AND THE VASCULATURE
    Willa Hsueh (Los Angeles, CA USA)

  • TREATMENT OF DIABETIC DYSLIPIDEMIA VERSUS GLYCEMIC
    Richard W. Nesto (Burlington, MA USA)*

  • PATHOBIOLOGY OF CVD IN DIABETES AND AN APPROACH TO ITS MANAGEMENT
    Alan Chait (Seattle, WA USA)

NOVEL APPROACHES TO ASSESSMENT OF RISK AND THERAPEUTIC RESPONSE

  • SECONDARY VERSUS PRIMARY PREVENTION: ARE NEW DEFINITIONS NEEDED?
    Sidney Smith (Chapel Hill, NC USA)

  • INFLAMMATORY BIOMARKERS: A NEW METHOD FOR RISK ASSESSMENT
    Paul Ridker (Boston, MA USA)

  • MRI
    Valentin Fuster (New York, NY USA)
PRESPECTIVES ON GLOBAL RISK: GUIDELINES AND BEYOND

  • US PERSPECTIVES
    Scott Grundy (Dallas, TX USA)

  • A EUROPEAN PERSPECTIVE ON GUIDELINES AND GLOBAL RISK OF CORONARY ARTERY DISEASE
    Ole Faergeman (Aarhus, Denmark)

  • JAPANESE PERSPECTIVES
    Yuji Matsuzawa (Kyoto, Japan)

  • AN ASIAN PACIFIC REGIONAL VIEWPOINT
    Edward Janus (Malvern, Australia)

  • FUTURE DIRECTIONS
    A.M. Gotto, Jr. (New York, NY USA)
    Rodolfo Paoletti (Milan, Italy)

SPECIAL LECTURE
  • THE GENETICS OF ATHEROSCLEROSIS
    Jan Breslow (New York, NY USA)

 

 

back
top page